| pubmed-article:12365018 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12365018 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:12365018 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:12365018 | lifeskim:mentions | umls-concept:C0153690 | lld:lifeskim |
| pubmed-article:12365018 | lifeskim:mentions | umls-concept:C0020437 | lld:lifeskim |
| pubmed-article:12365018 | lifeskim:mentions | umls-concept:C0070099 | lld:lifeskim |
| pubmed-article:12365018 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
| pubmed-article:12365018 | lifeskim:mentions | umls-concept:C0040223 | lld:lifeskim |
| pubmed-article:12365018 | lifeskim:mentions | umls-concept:C0545082 | lld:lifeskim |
| pubmed-article:12365018 | lifeskim:mentions | umls-concept:C1522602 | lld:lifeskim |
| pubmed-article:12365018 | lifeskim:mentions | umls-concept:C0444706 | lld:lifeskim |
| pubmed-article:12365018 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:12365018 | pubmed:dateCreated | 2002-10-4 | lld:pubmed |
| pubmed-article:12365018 | pubmed:abstractText | Parathyroid hormone-related protein (PTH-rP) is a major cause of tumor-induced hypercalcemia (TIH) and frequently is found to be elevated in serum of patients with TIH. In the current study, the authors examined the usefulness of PTH-rP measurement at the time of first presentation in the follow-up of lung carcinoma patients with TIH. | lld:pubmed |
| pubmed-article:12365018 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12365018 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12365018 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:12365018 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12365018 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12365018 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12365018 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12365018 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12365018 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:12365018 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:12365018 | pubmed:author | pubmed-author:KiuraKatsuyuk... | lld:pubmed |
| pubmed-article:12365018 | pubmed:author | pubmed-author:UeokaHiroshiH | lld:pubmed |
| pubmed-article:12365018 | pubmed:author | pubmed-author:HaradaMineM | lld:pubmed |
| pubmed-article:12365018 | pubmed:author | pubmed-author:YonedaToshiyu... | lld:pubmed |
| pubmed-article:12365018 | pubmed:author | pubmed-author:HirakiAkioA | lld:pubmed |
| pubmed-article:12365018 | pubmed:author | pubmed-author:TanimotoMitsu... | lld:pubmed |
| pubmed-article:12365018 | pubmed:author | pubmed-author:TakigawaNagio... | lld:pubmed |
| pubmed-article:12365018 | pubmed:author | pubmed-author:EguchiKenjiK | lld:pubmed |
| pubmed-article:12365018 | pubmed:author | pubmed-author:BesshoAkihiro... | lld:pubmed |
| pubmed-article:12365018 | pubmed:author | pubmed-author:SegawaYoshihi... | lld:pubmed |
| pubmed-article:12365018 | pubmed:copyrightInfo | Copyright 2002 American Cancer Society. | lld:pubmed |
| pubmed-article:12365018 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12365018 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:12365018 | pubmed:volume | 95 | lld:pubmed |
| pubmed-article:12365018 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12365018 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12365018 | pubmed:pagination | 1706-13 | lld:pubmed |
| pubmed-article:12365018 | pubmed:dateRevised | 2006-6-29 | lld:pubmed |
| pubmed-article:12365018 | pubmed:meshHeading | pubmed-meshheading:12365018... | lld:pubmed |
| pubmed-article:12365018 | pubmed:meshHeading | pubmed-meshheading:12365018... | lld:pubmed |
| pubmed-article:12365018 | pubmed:meshHeading | pubmed-meshheading:12365018... | lld:pubmed |
| pubmed-article:12365018 | pubmed:meshHeading | pubmed-meshheading:12365018... | lld:pubmed |
| pubmed-article:12365018 | pubmed:meshHeading | pubmed-meshheading:12365018... | lld:pubmed |
| pubmed-article:12365018 | pubmed:meshHeading | pubmed-meshheading:12365018... | lld:pubmed |
| pubmed-article:12365018 | pubmed:meshHeading | pubmed-meshheading:12365018... | lld:pubmed |
| pubmed-article:12365018 | pubmed:meshHeading | pubmed-meshheading:12365018... | lld:pubmed |
| pubmed-article:12365018 | pubmed:meshHeading | pubmed-meshheading:12365018... | lld:pubmed |
| pubmed-article:12365018 | pubmed:meshHeading | pubmed-meshheading:12365018... | lld:pubmed |
| pubmed-article:12365018 | pubmed:meshHeading | pubmed-meshheading:12365018... | lld:pubmed |
| pubmed-article:12365018 | pubmed:meshHeading | pubmed-meshheading:12365018... | lld:pubmed |
| pubmed-article:12365018 | pubmed:meshHeading | pubmed-meshheading:12365018... | lld:pubmed |
| pubmed-article:12365018 | pubmed:meshHeading | pubmed-meshheading:12365018... | lld:pubmed |
| pubmed-article:12365018 | pubmed:meshHeading | pubmed-meshheading:12365018... | lld:pubmed |
| pubmed-article:12365018 | pubmed:meshHeading | pubmed-meshheading:12365018... | lld:pubmed |
| pubmed-article:12365018 | pubmed:meshHeading | pubmed-meshheading:12365018... | lld:pubmed |
| pubmed-article:12365018 | pubmed:meshHeading | pubmed-meshheading:12365018... | lld:pubmed |
| pubmed-article:12365018 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12365018 | pubmed:articleTitle | Parathyroid hormone-related protein measured at the time of first visit is an indicator of bone metastases and survival in lung carcinoma patients with hypercalcemia. | lld:pubmed |
| pubmed-article:12365018 | pubmed:affiliation | Department of Medicine II, Okayama University Medical School, Okayama, Japan. ahiraki@md.okayama-u.ac.jp | lld:pubmed |
| pubmed-article:12365018 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12365018 | lld:pubmed |
